While CRC cells harboring KRAS mutation and expressing higher levels of HES1 displayed increased migration and altered EMT marker expression upon Hes1 down-regulation, inhibition on cellular proliferation by HES1 downregulation was not observed. This evidence concerns the gene KRAS and colorectal carcinoma.